This site is intended for Healthcare Professionals only.

CCA seeks clear guidance for healthcare settings as government rolls back Covid curbs

Date:

Share post:

Following the prime minister Boris Johnson’s recent announcement about ramping down the Covid-related restrictions in the country, the Company Chemists’ Association has called for a clear guidance for patients and staff in healthcare settings including pharmacies.

On Monday (February 21), Johnson announced in parliament that the legal requirement to self-isolate following a positive Covid test in England would end on Thursday (February 24).

“From this Thursday… we will end the legal requirement to self-isolate following a positive test,” he told MPs.

Raising concerns over the announcement, the CCA said: “Whilst we recognise many people will welcome this latest relaxation of Covid-19 restrictions, the government must now urgently publish guidance on testing and self-isolation for staff in healthcare settings and specifically community pharmacies.

“This will allow pharmacies sufficient time to implement any changes. Pharmacies, like any other healthcare environment, are regularly visited by clinically vulnerable individuals and we want to do our utmost to protect them.”

The association also sought clarity over how the changes would affect the Infection Prevention and Control guidance, “specifically around the use face coverings in healthcare settings for both the public and healthcare workers.”

Zero-tolerance to abuse

Highlighting recent incidents of abusive behavior faced by pharmacists and other staff in pharmacies, the CCA urged the government to set out a zero-tolerance approach to any abuse.

Short supply of lateral flow tests in pharmacies over Christmas pushed pharmacy staff to bear the brunt from frustrated customers.

The CCA stated: “We also need urgent guidance to allow pharmacies to facilitate a smooth withdrawal of lateral flow tests for the non-clinically vulnerable members of the public, ensuring that everybody who wants to can buy a test from 1 April.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

DHSC Plans to Allow Hub and Spoke Models Across Different Pharmacy Ownerships Soon

It has decided to proceed with the implementation of the two hub and spoke models that it consulted...

NHS Long Term Workforce Plan: 350 more medical school places allocated

The Office for Students (OfS) has targeted under-doctored areas in its allocation of the medical school places The government has...

Continuing royal legacy: RPS appoints King Charles as new patron

King Charles's patronage signals a new era of support for the RPS's mission to advance healthcare and patient-well...

Cipla, Glenmark recall products from US market due to manufacturing issues

Cipla USA is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution   Two Indian pharmaceutical companies,...